Residency · Austin, TX
Sponsored by University of Texas at Austin Dell Medical School
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
The New England journal of medicine · 2025 · 227 citations · Cynthia Brinson
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
The New England journal of medicine · 2021 · 851 citations · Cynthia Brinson
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA · 2022 · 229 citations · Cynthia Brinson
A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19.
Scientific reports · 2021 · 192 citations · Navkiran Shokar
Independent real-world application of a clinical-grade automated prostate cancer detection system.
The Journal of pathology · 2021 · 132 citations · Rodrigo Ceballos
Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection.
Archives of pathology & laboratory medicine · 2023 · 77 citations · Rodrigo Ceballos
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
The lancet. HIV · 2023 · 66 citations · Cynthia Brinson
Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study.
Annals of internal medicine · 2026 · 9 citations · Cynthia Brinson